CN117222437A - 构象切换的纳米结构 - Google Patents

构象切换的纳米结构 Download PDF

Info

Publication number
CN117222437A
CN117222437A CN202280030065.3A CN202280030065A CN117222437A CN 117222437 A CN117222437 A CN 117222437A CN 202280030065 A CN202280030065 A CN 202280030065A CN 117222437 A CN117222437 A CN 117222437A
Authority
CN
China
Prior art keywords
nanostructure
molecule
coupling
entity
sites
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202280030065.3A
Other languages
English (en)
Chinese (zh)
Inventor
沃特·艾林戈
克里斯蒂安·西格
亨德里克·迪兹
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Technical University of Munich
Original Assignee
Technical University of Munich
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Technical University of Munich filed Critical Technical University of Munich
Publication of CN117222437A publication Critical patent/CN117222437A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/35—Valency

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CN202280030065.3A 2021-04-22 2022-04-22 构象切换的纳米结构 Pending CN117222437A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP21169934.3A EP4079330A1 (en) 2021-04-22 2021-04-22 Conformation switching nanostructures
EP21169934.3 2021-04-22
PCT/EP2022/060737 WO2022223802A1 (en) 2021-04-22 2022-04-22 Conformation switching nanostructures

Publications (1)

Publication Number Publication Date
CN117222437A true CN117222437A (zh) 2023-12-12

Family

ID=75659780

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202280030065.3A Pending CN117222437A (zh) 2021-04-22 2022-04-22 构象切换的纳米结构

Country Status (6)

Country Link
US (1) US20240199763A1 (cg-RX-API-DMAC7.html)
EP (2) EP4079330A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024515346A (cg-RX-API-DMAC7.html)
KR (1) KR20230175241A (cg-RX-API-DMAC7.html)
CN (1) CN117222437A (cg-RX-API-DMAC7.html)
WO (1) WO2022223802A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4399528A1 (en) 2021-09-09 2024-07-17 Nautilus Subsidiary, Inc. Characterization and localization of protein modifications
EP4764494A1 (en) * 2024-12-20 2026-06-24 Plectonic Biotech GmbH Conjugates for analyte detection and quantification

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020254684A1 (en) * 2019-06-21 2020-12-24 Tilibit Nanosystems Gmbh Conditionally switchable nanostructure

Also Published As

Publication number Publication date
US20240199763A1 (en) 2024-06-20
EP4326342A1 (en) 2024-02-28
JP2024515346A (ja) 2024-04-09
KR20230175241A (ko) 2023-12-29
WO2022223802A1 (en) 2022-10-27
EP4079330A1 (en) 2022-10-26

Similar Documents

Publication Publication Date Title
Rinoldi et al. Nanotechnology‐assisted RNA delivery: from nucleic acid therapeutics to COVID‐19 vaccines
Jain et al. Comparison of avidin, neutravidin, and streptavidin as nanocarriers for efficient siRNA delivery
Edwardson et al. Virus-inspired function in engineered protein cages
Yang et al. Self-assembled double-bundle DNA tetrahedron for efficient antisense delivery
Nagamune Biomolecular engineering for nanobio/bionanotechnology
van der Meel et al. Next-generation materials for nucleic acid delivery
Panté et al. Nuclear pore complex is able to transport macromolecules with diameters of∼ 39 nm
Céspedes et al. In vivo architectonic stability of fully de novo designed protein-only nanoparticles
CN108175759B (zh) 一种抗肿瘤靶向给药系统及其制备方法与应用
Mukherjee et al. Galactose functionalized mesoporous silica nanoparticles as delivery vehicle in the treatment of hepatitis C infection
Chen et al. Framework nucleic acid nanomaterials for central nervous system therapies: design for barrier penetration, targeted delivery, cellular uptake, and endosomal escape
Liu et al. Factors determining the efficacy of nuclear delivery of antisense oligonucleotides by gold nanoparticles
Shi et al. Virus mimetic framework DNA as a non-LNP gene carrier for modulated cell endocytosis and apoptosis
Yamada et al. Development of a nanoparticle that releases nucleic acids in response to a mitochondrial environment
US20240199763A1 (en) Conformation switching nanostructures
Menon et al. Designer, Programmable DNA‐peptide hybrid materials with emergent properties to probe and modulate biological systems
Nasu et al. Nanopore-controlled dual-surface modifications on artificial protein nanocages as nanocarriers
Ingle et al. Polyplexes are endocytosed by and trafficked within filopodia
Li et al. Intranuclear delivery of DNA nanostructures via cellular mechanotransduction
Tang et al. Augmenting the Precise Targeting of Antimicrobial Peptides (AMPs) and AMP‐Based Drug Delivery via Affinity‐Filtering Strategy
Soliman et al. Responsive polyelectrolyte complexes for triggered release of nucleic acid therapeutics
Lee et al. Protein cages engineered for interaction-driven selective encapsulation of biomolecules
WO2016197264A1 (zh) 一种结合异核苷修饰、末端肽缀合及阳离子脂质体的小干扰rna修饰方法及制剂
Ojha et al. Virus as a nanocarrier for drug delivery redefining medical therapeutics-a status report
Khorenko et al. Foscarnet-type inorganic-organic hybrid nanoparticles for effective antiviral therapy

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination